+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Breast Cancer Screening Market, By Test Type; By End User-Estimation & Forecast, 2017-2030

  • PDF Icon

    Report

  • 193 Pages
  • July 2023
  • Region: Global
  • Astute Analytica
  • ID: 5864774
Description Jump to:

Global Breast Cancer Screening Market: Poised to Reach US$ 15.01 Bn by 2030

With an estimated value of US$ 7.46 Bn in 2022, the global Breast Cancer Screening market is expected to experience a substantial surge over the next eight years, reaching a market size of US$ 15.01 Bn by 2030. The market is expected to grow at a CAGR of 9.49% due to increasing breast cancer prevalence and a growing geriatric population.

Growth Influencers:

The rising prevalence of breast cancer worldwide and an increasing geriatric population are significant drivers of the Breast Cancer Screening market. However, the market's growth is hampered by the high costs of screening tests and uncertainties surrounding reimbursement policies related to breast cancer molecular diagnostics.

Segments Overview:

The market is segmented by test type and end user.

By Test Type

  • Imaging Tests
  • Ultrasound
  • MRI
  • Mammogram
  • Film mammography
  • Digital mammography

Digital breast tomosynthesis (DBT)

  • Genetic Tests
  • Other screening Tests

By End User

  • Research Labs
  • Cancer Institutes
  • Diagnostics Centers
  • Others
Imaging tests are forecasted to exceed US$ 9000 Mn by 2030 in terms of revenue. Diagnostic centers hold more than 30% of the market share in 2022, while the 'Others' segment, including private clinics and hospitals, is expected to witness the highest CAGR of more than 9%.

Regional Overview:

On the bases of region, the market is segmented into North America, Europe, Asia Pacific, South America, Middle East & Africa.

North America

  • US
  • Canada
  • Mexico

Europe

  • Western Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Russia
  • Poland
  • Rest of Eastern Europe

Asia Pacific

  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Singapore
  • Rest of ASEAN
  • Rest of Asia Pacific

Middle East & Africa

  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA

South America

  • Brazil
  • Argentina
  • Rest of South America
Regionally, North America dominates the market, holding more than 30% of the market share in 2022 with revenue of US$ 2355.9 Mn. The region's dominance is attributed to advanced healthcare infrastructure, rising awareness about early detection, and favorable reimbursement policies.

Competitive Landscape:

The market is characterized by competition among key players such as Siemens Healthcare, Hologic, Inc., Myriad Genetics, Metabolomic Technologies Inc., Biocrates Lifesciences AG, A&G Pharmaceuticals, Provista Diagnostics Inc., Roche Diagnostics, Lineage Cell Therapeutics, Inc. (Biotime Inc.), General Electric Company, Quest Diagnostics, Agendia NV, Oncocyte Corporation, Allengers Medical Systems Ltd., and others, collectively accounting for a market share close to 35%.

Report Insight:

  • Detailed analysis of market segments
  • Comprehensive understanding of growth influencers
  • In-depth regional market overview
  • Profound insights into the competitive landscape
  • Future market growth predictions

Questions to be Answered in the Report:

  • What are the key trends and opportunities in the Breast Cancer Screening market?
  • What will be the market size and growth rate by 2030?
  • Who are the major players in the Breast Cancer Screening market?
  • What are the key drivers and restraints of the market?
  • What are the emerging trends in breast cancer screening?

Table of Contents

Chapter 1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
Chapter 2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Sources
2.2. Quantitative Research
2.2.1. Primary & Secondary Sources
2.3. Breakdown of Primary Research Respondents, By Region
2.4. Assumption for the Study
2.5. Market Size Estimation
2.6. Data Triangulation
Chapter 3. Executive Summary: Global Breast Cancer Screening Market
Chapter 4. Global Breast Cancer Screening Market Overview
4.1. Industry Value Chain Analysis
4.1.1. Raw Material Supplier
4.1.2. Manufacturer
4.1.3. Distributor
4.1.4. End User
4.2. Industry Outlook
4.2.1. Cancer Statistics, 2022
4.2.2. Breast Cancer Screening Rate, by Country
4.3. PESTLE Analysis
4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition
4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Opportunities
4.5.4. Key Trends
4.6. Covid-19 Impact Assessment on Market Growth Trend
4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Mn), 2017 - 2030
4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2022
4.8.3. Competitor Mapping
4.9. Regulatory Landscape
Chapter 5. Global Breast Cancer Screening Market, By Test Type
5.1. Key Insights
5.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
5.2.1. Imaging Tests
5.2.1.1. Ultrasound
5.2.1.2. MRI
5.2.1.3. Mammogram
5.2.1.3.1. Film mammography
5.2.1.3.2. Digital mammography
5.2.1.3.3. Digital breast tomosynthesis (DBT)
5.2.2. Genetic Tests
5.2.3. Other screening Tests
Chapter 6. Global Breast Cancer Screening Market, By End User
6.1. Key Insights
6.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
6.2.1. Research Labs
6.2.2. Cancer Institutes
6.2.3. Diagnostics Centers
6.2.4. Others
Chapter 7. Global Breast Cancer Screening Market Analysis, By Region
7.1. Key Insights
7.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
7.2.1. North America
7.2.1.1. The U.S.
7.2.1.2. Canada
7.2.1.3. Mexico
7.2.2. Europe
7.2.2.1. Western Europe
7.2.2.1.1. The UK
7.2.2.1.2. Germany
7.2.2.1.3. France
7.2.2.1.4. Italy
7.2.2.1.5. Spain
7.2.2.1.6. Rest of Western Europe
7.2.2.2. Eastern Europe
7.2.2.2.1. Poland
7.2.2.2.2. Russia
7.2.2.2.3. Rest of Eastern Europe
7.2.3. Asia Pacific
7.2.3.1. China
7.2.3.2. India
7.2.3.3. Japan
7.2.3.4. South Korea
7.2.3.5. Australia & New Zealand
7.2.3.6. ASEAN
7.2.3.7. Rest of Asia Pacific
7.2.4. Middle East & Africa (MEA)
7.2.4.1. UAE
7.2.4.2. Saudi Arabia
7.2.4.3. South Africa
7.2.4.4. Rest of MEA
7.2.5. South America
7.2.5.1. Brazil
7.2.5.2. Argentina
7.2.5.3. Rest of South America
Chapter 8. North America Breast Cancer Screening Market Analysis
8.1. Key Insights
8.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
8.2.1. By Test Type
8.2.2. By End User
8.2.3. By Country
Chapter 9. Europe Breast Cancer Screening Market Analysis
9.1. Key Insights
9.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
9.2.1. By Test Type
9.2.2. By End User
9.2.3. By Country
Chapter 10. Asia Pacific Breast Cancer Screening Market Analysis
10.1. Key Insights
10.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
10.2.1. By Test Type
10.2.2. By End User
10.2.3. By Country
Chapter 11. Middle East & Africa Breast Cancer Screening Market Analysis
11.1. Key Insights
11.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
11.2.1. By Test Type
11.2.2. By End User
11.2.3. By Country
Chapter 12. South America Breast Cancer Screening Market Analysis
12.1. Key Insights
12.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
12.2.1. By Test Type
12.2.2. By End User
12.2.3. By Country
Chapter 13. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, Measurement Methods and Business Strategy Outlook)
13.1. Siemens Healthcare
13.2. Hologic, Inc
13.3. Myriad Genetics
13.4. Metabolomic Technologies Inc
13.5. Biocrates Lifesciences AG
13.6. A&G Pharmaceuticals
13.7. Provista Diagnostics Inc
13.8. Roche Diagnostics
13.9. Lineage Cell Therapeutics, Inc. (Biotime Inc.)
13.10. General Electric Company
13.11. Quest Diagnostics
13.12. Agendia NV
13.13. Oncocyte Corporation
13.14. Allengers Medical Systems Ltd.
13.15. Other Prominent Players

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Siemens Healthcare
  • Hologic, Inc
  • Myriad Genetics
  • Metabolomic Technologies Inc
  • Biocrates Lifesciences AG
  • A&G Pharmaceuticals
  • Provista Diagnostics Inc
  • Roche Diagnostics
  • Lineage Cell Therapeutics, Inc. (Biotime Inc.)
  • General Electric Company
  • Quest Diagnostics
  • Agendia NV
  • Oncocyte Corporation
  • Allengers Medical Systems Ltd.

Table Information

Report AttributeDetails
No. of Pages193
PublishedJuly 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 7.46 Billion
Forecasted Market Value ( USD ) by 2030 $ 15.01 Billion
Compound Annual Growth Rate9.4%
Regions CoveredGlobal

Related Topics

Related Reports

Breast Cancer Screening - Global Strategic Business Report - Product Image

Breast Cancer Screening - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Global Breast Cancer Screening Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

Global Breast Cancer Screening Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 115 Pages
  • Global
From
Next-Generation Breast Cancer Diagnostic and Screening Market - A Global Market and Regional Analysis: Focus on Technology, Cancer Sub-Type, Biomarker, Offering, End User, and Country Analysis - Analysis and Forecast, 2023-2032 - Product Image

Next-Generation Breast Cancer Diagnostic and Screening Market - A Global Market and Regional Analysis: Focus on Technology, Cancer Sub-Type, Biomarker, Offering, End User, and Country Analysis - Analysis and Forecast, 2023-2032

  • Report
  • 244 Pages
  • Global
From
Breast Cancer Diagnostics Global Market Report 2024 - Product Image

Breast Cancer Diagnostics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Next-Generation Breast Cancer Diagnostic & Screening Market by Product, Diagnostic Technology, Screening Technology, Application, End User - Forecast 2024-2030 - Product Image

Global Next-Generation Breast Cancer Diagnostic & Screening Market by Product, Diagnostic Technology, Screening Technology, Application, End User - Forecast 2024-2030

  • Report
  • 192 Pages
  • Global
From

About the Breast Cancer Screening Market

The Breast Cancer Screening market is a key component of Women's Health. It is a preventative measure that helps to detect breast cancer in its early stages, when it is most treatable. Screening typically involves mammography, which is an X-ray imaging test that can detect changes in the breast tissue. Other screening methods include clinical breast exams, breast ultrasounds, and MRI scans. The Breast Cancer Screening market is a growing industry, with many companies offering services to women. These companies provide a range of services, from mammography to MRI scans, to help women detect breast cancer early. Companies in the Breast Cancer Screening market include Breastlink, Breast Cancer Diagnostics, and Breast Health Solutions. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.